AlphaYouHT
Insider selling
Helen Torley sold $6.4M of Halozyme Therapeutics, Inc. (HALO) stock
Helen Torley, President And CEO of Halozyme Therapeutics, Inc. (HALO), sold 60,000 shares of HALO stock worth $6.4M, per an SEC Form 4 filed Sep 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 9, 2026, 3 days before it was made public.
HALO has moved +3.8% since the trade date, from $107.39 to $111.45 (Sep 21, 2026 close).
- Traded
- Sep 9, 2026
- Disclosed
- Sep 12, 2026
- Filing delay
- 3 days
- Price since
- +3.8%
- Role
- President And CEO
- Source
- SEC Form 4
More HALO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.